Conversion of Sox2-dependent Merkel cell carcinoma to a differentiated neuron-like phenotype by T antigen inhibition by Harold, Alexis et al.
Conversion of Sox2-dependent Merkel cell carcinoma
to a differentiated neuron-like phenotype by
T antigen inhibition
Alexis Harolda,1, Yutaka Amakoa,b,1, Junichi Hachisukac,d, Yulong Baie, Meng Yen Lif, Linda Kubatg, Jan Gravemeyerg,
Jonathan Franksh, Julia R. Gibbsa, Hyun Jung Parke, Elena Ezhkovaf, Jürgen C. Beckerg, and Masahiro Shudaa,b,2
aCancer Virology Program, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15213; bDepartment of Microbiology and
Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219; cPittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, PA 15213;
dDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA 15213; eDepartment of Human Genetics, University of Pittsburgh, Pittsburgh,
PA 15260; fThe Tisch Cancer Institute, Black Family Stem Cell Institute, Department of Cell, Developmental, and Regenerative Biology, Icahn School of Medicine
at Mount Sinai, New York, NY 10029; gTranslational Skin Cancer Research, Dermatology, German Cancer Consortium (DKTK), 45141 Essen, Germany;
and hCenter for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA 15261
Edited by Thomas E. Shenk, Princeton University, Princeton, NJ, and approved August 21, 2019 (received for review April 29, 2019)
Viral cancers show oncogene addiction to viral oncoproteins,
which are required for survival and proliferation of the dediffer-
entiated cancer cell. Human Merkel cell carcinomas (MCCs) that
harbor a clonally integrated Merkel cell polyomavirus (MCV) genome
have low mutation burden and require viral T antigen expression for
tumor growth. Here, we showed that MCV+ MCC cells cocultured
with keratinocytes undergo neuron-like differentiation with neurite
outgrowth, secretory vesicle accumulation, and the generation of
sodium-dependent action potentials, hallmarks of a neuronal cell line-
age. Cocultured keratinocytes are essential for induction of the neu-
ronal phenotype. Keratinocyte-conditioned medium was insufficient
to induce this phenotype. Single-cell RNA sequencing revealed that T
antigen knockdown inhibited cell cycle gene expression and reduced
expression of key Merkel cell lineage/MCC marker genes, including
HES6, SOX2, ATOH1, and KRT20. Of these, T antigen knockdown di-
rectly inhibited Sox2 and Atoh1 expression. MCV large T up-regulated
Sox2 through its retinoblastoma protein-inhibition domain, which in
turn activated Atoh1 expression. The knockdown of Sox2 in MCV+
MCCs mimicked T antigen knockdown by inducing MCC cell growth
arrest and neuron-like differentiation. These results show Sox2-
dependent conversion of an undifferentiated, aggressive cancer cell
to a differentiated neuron-like phenotype and suggest that the on-
tology of MCC arises from a neuronal cell precursor.
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Several types of cancer cells, specifically those that are addictedto a given oncogene activation or tumor-suppressor in-
activation for tumorigenesis, revert from their malignant state to
normal state when the key oncogene is inhibited or tumor sup-
pressor is restored (1–3). The reversion of a malignant phenotype
has been often seen in cancer cells transformed by tumor viruses.
In various experimental models, cells transformed by tumor viruses,
such as Rous sarcoma virus and animal polyomaviruses like SV40,
are addicted to viral oncogene expression and have been shown to
revert to the original uninfected cells when the viral oncoprotein is
inhibited (4–6).
Merkel cell polyomavirus (MCV; MCPyV) is the most recently
identified human oncogenic polyomavirus that causes ∼80% of
Merkel cell carcinoma (MCC). MCV is clonally integrated in the
MCC tumor genome, which results in the persistent expression of
viral T oncogene in tumor cells (7). Similar to other polyomaviruses,
MCV T antigen encodes 2 major transcripts that express large T
(LT) and small T (sT) proteins. Viral sequence analysis in MCC
tumors showed that integrated LT antigens are C-terminally trun-
cated by tumor-specific polymorphisms, resulting in the loss of viral
replication capacity (8). Functional studies of sT and tumor-derived
LT antigens confirmed their tumorigenic potential (9). As seen in
SV40-immortalized cells, MCV+ MCC tumor cells show an onco-
genic addiction to viral oncogene expression: The inhibition of T
antigen expression by T antigen knockdown induces cell cycle arrest
and nonapoptotic cell death (10), which also leads to a loss of tu-
morigenicity in nude mice (11). However, a detailed analysis of the
MCC cells that lose T antigen expression has not been performed yet.
MCV+ MCCs have a lower mutation burden than MCV−MCC
and maintain a relatively intact genetic profile (12). Similar to
other virus-induced tumors, while p53 and retinoblastoma protein
(Rb) tumor-suppressor genes remain wild-type in MCV+ MCC
tumors (13, 14), their functions are likely to be suppressed directly
or indirectly by the viral T antigen oncogene. This is supported by
the fact that MCC tumorigenesis depends on viral T antigen ex-
pression and does not require a complex selection of genetic
mutations that favor cancer cell proliferation. Based on these
observations, we hypothesized that virus-positive MCC cancer
Significance
Normal cells can be transformed into cancer cells by viral on-
cogenes. Reversion of a viral human cancer cell, however, into
a differentiated cell by viral oncogene inhibition has not been
described. Merkel cell carcinoma (MCC) is a neuroendocrine
cancer caused by Merkel cell polyomavirus (MCV) that encodes
a T antigen oncogene. When MCV+ MCC cells with T antigen
knockdown are cocultured with keratinocytes, the MCC phe-
notype converts to a differentiated neuronal phenotype and
loses Merkel cell factor Sox2 and Atoh1 expression. MCV large
T activates Sox2 and Atoh1 by its ability to inhibit retinoblas-
toma. Sox2 inhibition similarly induced this phenotypic con-
version of MCC. These findings suggest that MCV induces
cancer by dysregulating embryonic Merkel cell differentiation
pathways.
Author contributions: A.H., Y.A., J.H., H.J.P., E.E., J.C.B., and M.S. designed research; A.H.,
Y.A., J.H., Y.B., M.Y.L., L.K., J.G., J.F., J.R.G., H.J.P., E.E., J.C.B., and M.S. performed research;
A.H., Y.A., J.H., Y.B., M.Y.L., L.K., J.G., J.F., J.R.G., H.J.P., E.E., J.C.B., and M.S. analyzed data;
and Y.A., J.H., Y.B., M.Y.L., J.G., J.F., H.J.P., E.E., J.C.B., and M.S. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This open access article is distributed under Creative Commons Attribution-NonCommercial-
NoDerivatives License 4.0 (CC BY-NC-ND).
Data deposition: The single-cell sequence dataset reported in this paper has been de-
posited in the Gene Expression Omnibus (GEO) database, https://www.ncbi.nlm.nih.gov/
geo/ (accession no. GSE136867).
1A.H. and Y.A. contributed equally to this work.
2To whom correspondence may be addressed. Email: mas253@pitt.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1907154116/-/DCSupplemental.











cells may retain the capacity to be reverted into an untransformed
state by T antigen inhibition.
In the present study, in order to study the fate of MCC cancer
cells after the viral oncogene deprivation, we performed genet-
ical and cell biological analyses on MCV+MCC cells with viral T
antigen knockdown. We found that in vitro T antigen knockdown
in MCV+ MCC cells with cocultured human keratinocytes alters
its round suspension cell morphology to adherent cell mor-
phology and confers neuronal phenotypes, including neurite
outgrowth, cytosolic vesicle accumulation, and sodium channel-
dependent excitability. MCC are neuroendocrine tumors with
morphologic and immunophenotypic similarities to Merkel cells
(15). Transcriptional profiling of the Merkel cells in mouse skin
showed that these cells express neuronal transcription factors,
presynaptic molecules, and ion-channel subunits (16, 17). Of
them, Atoh1 and Sox2 are critical transcription factors for
Merkel cell development, in which Atoh1 plays a role in Merkel
cell specification, while Sox2 controls Merkel cell maturation
(18–21). Our single-cell RNA sequencing study demonstrated
that the inhibition of viral T antigen in MCC cells enforces cell
cycle exit, shutting off cell cycle-associated gene expression, and
simultaneously decreases the expression of the key Merkel cell
lineage factors and MCC markers, including Sox2 and Atoh1.
We found that viral LT is responsible for the Sox2 activation and
that Sox2 is a direct upstream transcriptional activator of
ATOH1. Finally, the Sox2 knockdown study revealed that
Sox2 plays a critical role in both MCV+ MCC cell proliferation
and maintenance of the MCC phenotype. Our data demonstrate
that MCV-associated human MCC is a human cancer that can
revert to an untransformed state and acquire a differentiated
neuron-like phenotype, and that the viral activation of
Sox2 serves as a key switch for this phenotypic conversion.
Results
MCV T Antigen Knockdown in MCV+MCC Cells Promotes Morphological
Alteration with Cocultured Keratinocytes.Merkel cells localize to the
basal layer of the epidermis and are in direct association with
keratinocytes. To mimic Merkel cells or MCC growth in situ, we
cocultured MCV+ MCC cells with human keratinocytes. We ini-
tially used MCV+ MCC cells MKL-1, MKL-2, MS-1, WaGa, and
CVG-1 (10, 22), which grow in suspension culture, forming
loose clusters when cultured in the standard 10% FCS RPMI
medium or keratinocyte growth medium (SI Appendix, Fig.
S1A). When cocultured with human keratinocytes in the kera-
tinocyte growth medium, the MCC cells became disaggregated
into round cells, and a subset of the cells attached to the cell
culture dishes. Cocultured keratinocytes were distinguished
from MCC cells based on the large cell size and intracellular
granules seen in the differentiated keratinocytes. Among the
attached MCC cells, we observed morphologically distinct
MCC cells with cytoplasmic projections. This morphological
alteration was not seen in MCC cells grown with the condi-
tioned medium from the keratinocyte culture or in transwell
cocultured MCC cells with keratinocytes, suggesting that se-
creted factors from keratinocytes are not sufficient to induce
morphological changes in MCC cells (SI Appendix, Fig. S1B).
This outgrowth of cellular processes was observed most fre-
quently in CVG-1, followed by MKL-2 and MS-1 cells. We
tested whether MCV T antigen expression affects this mor-
phological alteration by using a lentiviral short-hairpin RNA
(shRNA) that targets all T antigen isoforms (10, 23). For the
rest of the experiments, we used MS-1 and CVG-1 cells, early-
passage cell lines established by our group (22, 24), and MKL-2
cells, an extended-passage cell line established by Martin et al.
(25) prior to the discovery of MCV (10). These MCV+ MCC
cell lines were transduced with GFP-expressing control shRNA
(shCtrl-eGFP) or shpanT-eGFP that targets all T antigen isoform
transcripts, and then the shRNA-transduced cells were cocultured
with keratinocytes. After 5 d of coculture, cell morphology was
evaluated under a fluorescence microscope. T antigen knockdown
in MS-1, MKL-2, and CVG-1 cells significantly increased the
number of eGFP+ cells displaying short and large cellular pro-
jections (Fig. 1A and SI Appendix, Fig. S1C). Immunofluorescence
staining confirmed that the projections are neurofilament L+
(NFL+) neurites in most of the shpanT-transduced MS-1 and
CVG-1 cells (83.7 ± 2.7% and 86.5 ± 2.7%, P < 0.05 for MS-1 and
CVG-1, respectively) (Fig. 1B and SI Appendix, Fig. S1D). We
graded the neurite outgrowth on a scale of 0 to 3 according to the
presence of the cellular process and the length of projections
relative to a cell size (SI Appendix, Fig. S1E). Cells with longer,
polarized grade 2 and 3 projections were significantly increased by
T antigen knockdown in all 3 MCV+ MCC cells examined (Fig.
1C). Bromodeoxyuridine (BrdU) labeling experiments in cocul-
tured CVG-1 and MS-1 cells demonstrated that T antigen
knockdown ablates the BrdU+ MCC cells irrespective of cellular
neurite-positivity, while some keratinocytes incorporate BrdU (SI
Appendix, Fig. S1 F and G). These data are consistent with our
previous results showing that T antigen knockdown induces G0/
G1 arrest (10). We also examined the ultrastructure of the neu-
rite+ MS-1 and MKL-2 cells by electron microscopy (Fig. 1D and
SI Appendix, Fig. S1H). The focal accumulation of dense core
vesicles transported outward along cellular projection was de-
tected in shpanT-transduced MS-1 and MKL-2 cells, while vesicles
scattered in the cytoplasm were seen in shCtrl-transduced cells,
confirming that the mature neural phenotype is conferred by T
antigen knockdown in MCV+ MCC cells. The expression of
cholecystokinin, a synaptic neuropeptide that is expressed in
neuroendocrine Merkel cells as well as neurons (16, 26, 27), was
significantly induced in MKL-2 and CVG-1 cells by T antigen
knockdown (Fig. 1E).
Neurite+ MCV T Antigen Knockdown MCC Cells Fire Na+-Dependent
Action Potentials. To test the physiological property of the dif-
ferentiated MCC cells induced by T antigen knockdown, we
performed whole-cell patch-clamp recordings in MS-1 cells.
Resting membrane potentials ranged from −60 to −70 mV.
None of the control MCC cells showed action potential upon
current injection (Fig. 2A) (n = 9). In contrast, in the majority of
shpanT-transduced MS-1 cells (83%) displaying grade 3 neurite
outgrowth, the action potentials can be detected and blocked by
treatment with tetrodotoxin (TTX), a neurotoxin that inhibits
neuronal excitability by binding to voltage-gated sodium chan-
nels (Fig. 2B) (n = 12, χ2 test P = 0.0002 between shCtrl and
shpanT-transduced MS-1 cells). When compared to a repre-
sentative recording from a dorsal root ganglion neuron, however,
action potentials from differentiated MS-1 cells do not exhibit
clear afterhyperpolarization (SI Appendix, Fig. S2A). All re-
sponsive cells showed only a single spike upon current injection
(n = 10). Since Merkel cells fire Ca2+-action potentials (28), we
examined if Ca2+ is involved in these action potentials by using
artificial cerebrospinal fluid (ACSF) with or without calcium
depletion. TTX completely blocked action potentials, irre-
spective of calcium depletion (Fig. 2 C and D). Calcium-free
ACSF did not block action potentials (Fig. 2D), indicating that
voltage-gated sodium channels, but not voltage-gated calcium
channels, mediate this action potential. Consistent with this
function, among the 5 voltage-gated sodium channel genes
(SCN) examined, T antigen knockdown up-regulated the ex-
pression ofSCN3A and SCN9A in MS-1 cells (Fig. 2E). In MKL-2
cells and CVG-1 cells, 4 SCN genes—including SCN1A,
SCN2A, SCN3A, and SCN9A—were coordinately induced by
shpanT (Fig. 2E and SI Appendix, Fig. S2B). SCN8A was un-
changed in all 3 MCC cell lines (Fig. 2E and SI Appendix, Fig.
S2B). Since the nature of action potentials detected in the
neurite+ MS-1 cells differs from that in normal Merkel cells, the
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neurite+ cells induced from MCV+ MCC by T antigen knock-
down resemble neurons rather than Merkel cells.
The Loss of Viral T Antigen Down-Regulates Cell Cycle Genes and
Merkel Cell/MCC Marker Genes in MCV+ MCC Cells. In order to in-
vestigate the genetic changes associated with the morphological
alteration in MCC cells, we performed single-cell RNA se-
quencing using keratinocyte-cocultured CVG-1 cells with or
without T antigen knockdown (29). The cocultured CVG-1 cells
transduced with shpanT showed increased neurite formation as
compared to those with shCtrl when harvested (SI Appendix, Fig.
S3A). Even though the coculture was initiated with an equal
number of keratinocytes and CVG-1 cells, the overall density of
the shpanT-transduced cells was lower than the shCtrl cells due
to the growth arrest induced by T antigen knockdown.
The t-distributed stochastic neighboring (t-SNE) plot was
generated from 2 libraries derived from 8,766 keratinocyte-
cocultured shCtrl- and 9,456 shpanT-transduced CVG-1 cells
(Fig. 3A). It consists of 3 independent clusters (I ∼ III), in which
cluster I contains a majority of the shCtrl dataset, while cluster II
is composed of the shpanT dataset. Cluster III is a mixture of the
shCtrl and shpanT datasets. To analyze the difference in gene-
expression pattern in every single cell, we employed the k-
clustering algorithm and obtained 6 well-separated clusters
(Fig. 3 A, Right and SI Appendix, Fig. S3B). Cluster numbers are
given based on the cluster size. Clusters 1 (C1), C2, C4, and
C5 expressed MCC marker genes CHGA (chromogranin A) and
SYP (synaptophysin), while C3 highly expressed the keratinocyte
marker gene KRT14 (Fig. 3B). This indicates that C3 is a dataset





Fig. 1. MCV T antigen knockdown promotes the morphological alteration of MCC tumor cells into cells with a neurite structure in the presence of cocultured
keratinocytes. (A) MS-1 cells were transduced with GFP-coding shRNA, targeting all T antigen isoforms (shpanT-eGFP) and control shRNA (shCtrl-eGFP) for 3 d,
and then cocultured with human primary keratinocytes for 5 d. GFP+ MCC cells with T antigen knockdown exhibit distinct cytoplasmic projections. (Mag-
nification: 40×.) (B) Immunofluorescence staining of NFL using MS-1 cells with shpanT-puro, the cytoplasmic projections are NFL+ neurite. (Magnification:
40×.) (C) T antigen knockdown increases cells with elongated neurite structures (grades 2 and 3) in 3 MCV+MCC cells. The neurite formation was graded from
0 to 3 (SI Appendix, Fig. S1E). Grade 0 represents no process, grade 1 cellular process-positive, grade 2 polarized projections, and grade 3 with projection a
longer than 2-cell body sizes. Data are shown as average ± SE, *P < 0.05 (Student t test). (D) The production of dense core vesicles at the cellular projection in
neurite+ MCC cells. MS-1 and MKL-2 cells transduced with shCtrl-puro or shpanT-puro were puromycin-selected and subjected to observations by a trans-
mission electron microscopy. The arrow indicates dense core neuroendocrine granules shown in the magnified region. (E) T antigen knockdown increases
cholecystokinin (CCK) expression in MKL-2 and CVG-1 cells. The CCK mRNA expression was determined by qRT-PCR and normalized with the18S ribosomal
RNA control by the 2−ΔΔCT method. Data are shown as average ± SD, *P < 0.05 (Student t test).











represent a dataset from MCV+ CVG1 cells. MCV T antigen
expression was predominantly detected in C2, C4, and C5, which
overlaps with the dataset from the shCtrl library in cluster I (Fig.
3 A, Left and Fig. 3C). On the other hand, MCV T antigen
mRNA expression is markedly lower in C1, which overlaps with
the dataset from the shpanT library in cluster II (Fig. 3 A–C).
This result is consistent with efficient T antigen knockdown by
shpanT. Similar to C1, C6 and the keratinocyte-derived C3 do
not express MCV T antigen. While the majority of C6 consists of
the shCtrl dataset, T antigen expression was undetectable, and
the expression of both MCC and keratinocyte markers was low
(Fig. 3B). Because of the unclear cellular identity and the rela-
tively small cluster size, we excluded C6 from the current analysis
together with C3. Nonetheless, the clear separation of cluster I
and cluster II in t-SNE indicates that T antigen knockdown sig-
nificantly alters the cellular transcriptome in CVG-1 cells.
To further define C2, C4, and C5, we examined cell cycle
marker expression. C4 expresses G1/S-phase cell cycle markers,
including CCNE1, CDK2, and E2F1, while C5 is positive for S-
and G2/M-phase markers, including CCNA2, CCNB1, MKI67,
and AURKA (Fig. 3 B, Right and SI Appendix, Fig. S3C). The
expression of these cell cycle marker genes is nearly absent in
C1 and C2. Accordingly, we defined C1 to be noncycling CVG-1
cells with T antigen knockdown, and C2 to be noncycling CVG-1 cells
with control shRNA. C4 and C5 represent cycling CVG-1
control cells that commit G1/S and S/G2/M cell cycle phases,
respectively.
In order to study the gene-expression changes associated with
T antigen knockdown in CVG-1 cells, a differential gene ex-
pression (DE) analysis was performed between clusters C2/C4/
C5 and C1 (SI Appendix, Fig. S3D and Dataset S1). To validate
our DE analysis, we examined previously reported E2F target
genes (30), because MCV LT has been shown to activate E2F by
inhibiting Rb in MCC cells (31, 32). Among the 65 E2F target
genes expressed in C1, C2, C4, and C5, 60 genes showed negative
log fold-change (logFC) values in C1, suggesting that E2F target
genes are coordinately suppressed by T antigen knockdown (SI
Appendix, Fig. S3D and Dataset S1). In line with this result, ca-
nonical E2F target genes—including CCNE1, E2F1, CDK2,
CCNA2, and MKI67—were suppressed in C1 and C2 (Fig. 3B
and SI Appendix, Fig. S3C). This is consistent with the restora-
tion of Rb tumor-suppressor activity in T antigen knockdown
cells. Of 5 E2F targets up-regulated in C1, 3 genes were
AP1 genes: FOS, JUNB, and JUN (SI Appendix, Fig. S3D and
Dataset S1). Neuronal transmitters and transsynaptic stimulation





Fig. 2. Neurite+ MCC cells display neuronal, but not Merkel cell electrophysiological properties. (A) Representative trace of an MS-1 cell transduced with
shCtrl-puro. (Magnification: 40×.) Current injection (180 pA, 400 ms) did not cause action potentials (Left). TTX application had no effect (Right). (B) Sample
trace of an MS-1 cell transduced with shpanT-puro that displays grade 3 differentiation. Current injection (120 pA, 400 ms) caused an action potential (arrow,
left) that was blocked by TTX (0.5 μM). (C) The effect of TTX on the action potential of a shpanT-puro–transduced MCC cell. Step pulses from 0 to 340 pA were
applied. Action potentials observed in the control sample (black) were completely blocked by TTX (red). A TTX washout restores action potentials (green). The
current–voltage relationship is shown in a graph. (D) The effect of Ca-free ACSF on the action potentials of a Pan-T treated MCC cell. Step pulses from 0 to
400 pA were applied. Action potential is not blocked by Ca-free ACSF (light blue), but additional TTX does block the action potential in the absence of calcium
(orange). (E) Voltage-dependent sodium channel genes (SCN) are up-regulated by T antigen knockdown in MCV+ MS-1 and MKL-2 cells. qRT-PCR was
performed for SCN1A, SCN2A, SCN3A, SCN8A, and SCN9A, and relative expression to shCtrl transduced cells was determined by the 2−ΔΔCT method with
the18S ribosomal RNA control. Data are shown as average ± SD, *P < 0.05 (Student t test).
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unknown, the activation of AP1 genes in the T antigen knock-
down cells may represent the activated neuronal activities. Al-
though both C1 and C2 are datasets from noncycling cells, a
clear separation of noncycling C1 and C2 clusters on the t-SNE
indicates that T antigen knockdown in CVG-1 cells results in cell
cycle exit and further alters the transcriptome, which is even
distinct from noncycling shCtrl cells.
In the DE analysis, we also investigated MCC marker genes
(34–37) and Merkel cell marker genes, which have been pre-
viously characterized in Atoh1+ mouse Merkel cells as compared
to Atoh1− epidermal cells (16, 17). Atoh1 is the Merkel cell
lineage-determining transcription factor, which is essential for
Merkel cell development in mouse skin (18, 38). Merkel cell
transcription factors ATOH1, SOX2, HES6, and MCC marker
KRT20 showed negative logFC values as expressed lowly in C1 in
comparison to C2/C4/C5 (SI Appendix, Fig. S3D and Dataset S1).
Violin plots also confirmed that cells that highly express these
4 genes are markedly reduced in C1 (Fig. 3D). This reduction is
not a simple result of cell cycle exit by T antigen knockdown,
because the expression of these genes is also detected in
C2 derived from noncycling shCtrl CVG-1 cells (Fig. 3D). In
addition to these 4 markers, ENO2, BCL2, PAX5, and CD99
reported to be overexpressed in MCC cells (34–37) were also
down-regulated in C1 (SI Appendix, Fig. S3E). In contrast, other
known Merkel cell genes related to synaptic release machinery—
such as CADPS, CPE, PCSK, and SNAP25—were unchanged or
slightly increased in C1 (SI Appendix, Fig. S3 D and F), consistent
with active secretory vesicle accumulation in neurite+ MCC cells
(SI Appendix, Fig. S3F). Neurite and axonal markers, including
neurofilament L (NEFL) and Tau (MAPT), were also slightly
increased in C1 by T antigen knockdown. These data indicate
that genes expressed in Merkel cells and MCC are down-
regulated by viral T antigen knockdown, whereas markers
involved in neurosecretory functions are sustained or even
increased.
Viral T Antigen Maintains Expression of Merkel Cell Lineage Makers,
Sox2 and Atoh1 in MCC. Single-cell RNA sequencing data suggest
that Merkel cell lineage markers Sox2 and Atoh1, which play




Fig. 3. T antigen inhibition in MCV+ MCC cells ablates cell cycle-associated gene expression and decreases MCC and Merkel cell marker gene expression. (A)
t-SNE plot visualizing the datasets from shCtrl (blue) and shpanT (brown) single-cell sequencing libraries (Left). t-SNE plot visualizing 6 (C1 ∼ C6) cluster as-
signments of cells defined by k-clustering (Right). (B) Violin plots showing the distributions of the log-transformed average count of various marker genes in
each cell cluster. Keratinocyte (KRT14) and MCC (CHGA, and SYP) marker-gene expression defined C1, C2, C4, C5, and C6 as CVG-1 cells, and C3 as kerati-
nocytes. Cell cycle marker-gene expression analysis also defined C1, C2, and C6 as noncycling CVG-1 cells, and C4 and C5 as cycling CVG-1 cells in G1/S and in
S/G2/M, respectively. (C) A Violin plot (Left) illustrating the distribution of MCV T antigen expression in each cell cluster. Plot (Right) maps the log2-transformed
counts to a t-SNE result. (D) Violin plots illustrating the distributions of expression of Merkel cell and MCC marker genes in C1, C2, C4, and C5.











up-regulated by MCV T antigen in MCC. The expression of
Atoh1 and Sox2 in MCC tissues has been reported previously
(39, 40). In the 7 MCV+ MCC cell lines examined, Sox2 and
Atoh1 proteins were readily detectable by immunoblot (Fig. 4A).
Methylation analyses performed for Sox2 and Atoh1 promoters
revealed that CpG sequences within 1,500 bp from the tran-
scription start sites (TSS) are hypomethylated in MCV+ MKL-2,
WaGa, and MKL-1 cells, whereas those in MCV− MCC cells,
including MCC-13 and MCC-26, are highly methylated, consis-
tent with high levels of Sox2 and Atoh1 mRNA expression in
MCV+ MCC cells (Fig. 4B). Sox2 has a distinct upstream region
where MCV− MCC cells show more frequent CpG methylation
than MCV+ MCC cells (Chr 3 nucleotide position near
181,428,500) (SI Appendix, Fig. S4A). This region is only 1,000 bp
upstream of the Sox2 TSS, thereby in perfect range to contain
the promoter and well-conserved in vertebrates. Thus, CpG
hypermethylation in this region may regulate the low Sox2 ex-






Fig. 4. MCV T antigen activates Sox2 and Atoh1 expression in MCC cells. (A) Sox2 and Atoh1 proteins are expressed in all MCV+ MCC cells examined. (B)
Hypomethylation of Sox2 and Atoh1 promoters is correlated with higher mRNA expression of Sox2 and Atoh1 in MCV+ MCC cells. The number of CpG
methylation sites in Sox2 or Atoh1 promoters counted within 1,500 bp upstream from the TSS are much lower in MCV+ MCC cell lines (MKL-1, MKL-2, WaGa)
than in MCV− cell lines (MCC-13 and MCC-26). The mRNA expression (Lower) was inversely correlated with CpG methylation levels. (C) T antigen knockdown
decreases Sox2 and Atoh1 mRNA expression in MS-1, MKL-2, and CVG-1 cells. MCC cells transduced with shpanT-puro or shCtrl-puro were selected for 4 d with
puromycin and grown in fresh medium without puromycin for 2 d. qRT-PCR was performed for Sox2, Atoh1, and MCV T antigen using 18S rRNA for nor-
malization. The 2−ΔΔCT method was used to determine the relative mRNA abundance to shCtrl. Data are shown as average ± SD, *P < 0.05 (Student t test). (D)
Sox2 and Atoh1 protein expression is reduced by panT antigen knockdown in MS-1, MKL-2, and CVG-1 cells. Cells in B were subjected to LI-COR quantitative
immunoblot analyses with Sox2 and Atoh1. An LT immunoblot confirms knockdown of T antigen by shpanT-puro. Closed arrowheads indicate truncated LT
proteins. Hsp70 protein was detected as an internal control. Graphs indicate the quantitation of Sox2 and Atoh1 protein expression normalized by Hsp70.
Data are shown as average ± SE, *P < 0.05 (Student t test), Double asterisks (**) indicate nonspecific band. (E) Expression of nuclear Sox2 protein is attenuated
in the differentiated MS-1 cells displaying grade 2/3 neurite formation (arrowheads). DAPI staining represents the location of nucleus. No Sox2 protein
expression was detected from human keratinocytes used for coculture. (Magnification: 40×.) (F) Quantitation of Sox2 expression in different grade of
neurite+ cells. Sox2 protein expression was quantitated by ImageJ software. Values in y axis represent a nuclear Sox2 intensity after subtraction of a back-
ground. *P < 0.05 (Student t test).
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region is markedly lower in MCV+ cells than in MCV− cells,
and MCV− MCC exhibit more variation in their methylation
levels compared to MCV+ MCC (SI Appendix, Fig. S4B), sug-
gesting that CpG methylation may influence Atoh1 expression
in MCV− cells. When T antigen was knocked down in MS-1,
MKL-2 and CVG-1 cells, Sox2 and Atoh1 mRNA expression was
reduced, confirming the single-cell RNA sequencing results (Fig.
4C). In concordance with the mRNA expression, T antigen
knockdown also resulted in reduced Sox2 and Atoh1 protein levels,
as shown by immunoblot (Fig. 4D). When Sox2 and NFL proteins
were stained in shpanT-transduced MS-1 cells under keratino-
cyte coculture, Sox2 expression was significantly reduced in the
grade 1 to 3 neurite+ cells, as compared to round MS-1 cells
(grade 0) that retain high levels of nuclear Sox2 expression (Fig.
4 E and F), indicating that Sox2 expression is inversely associated
with neurite formation induced by T antigen knockdown.
Viral LT Up-Regulates Merkel Cell Lineage Markers, Sox2 and Atoh1,
and Inhibits Neurite+ Cell Formation. To determine which T anti-
gen isoform regulates Sox2 expression, we expressed codon-
optimized MCV sT and tumor-derived truncated 339 large T
(339LT) in keratinocytes (SI Appendix, Fig. S5A). qRT-PCR
analyses demonstrated that MCV 339LT specifically increases
Sox2 mRNA 2.5-fold (Fig. 5A). The induction of Sox2 mRNA
was not observed when the Rb-binding mutant, 339LT.LFCDK,
was expressed, suggesting that the Rb-targeting of LT is essential
for Sox2 induction. Next, the importance of LT expression on
Sox2 expression was investigated in MCC cells. We transduced
shRNA-resistant codon-optimized 339LT into MKL-2 cells to
examine if exogenous LT expression rescues Sox2 expression
upon endogenous T antigen knockdown. Both 339LT and
339LT.LFCDK were resistant to shpanT knockdown as expected,
whereas endogenous 40-kDa LT protein was significantly re-
duced by shpanT (Fig. 5B). Under these conditions, wild-type
339LT rescued Sox2 expression when the endogenous T anti-
gen was knocked down by G418-selectable shpanT-neo. We also
observed the restoration of Atoh1 protein expression by wild-
type 339LT, consistent with the LT regulation of Atoh1. In
contrast, the 339LFCDK mutant rescued neither Sox2 nor Atoh1
protein levels (Fig. 5B). Using the same cells, we tested if ex-
ogenous LT expression affects neurite+ cell formation induced
by T antigen knockdown under keratinocyte coculture. Expres-
sion of wild-type 339LT markedly reduced neurite+ cells in
MKL-2 cells, regardless of T antigen knockdown, while
339LFCDK mutant did not show a significant effect (Fig. 5 C and
D). Under T antigen knockdown, 339LT expression decreased
grade 2 and grade 3 neurite+ cells by 75% and by 65%, re-
spectively, as compared to shpanT-transduced MKL-2 empty
cells (Fig. 5D). A similar reduction in neurite+ cell numbers by
339LT expression was also seen in MS-1 cells (SI Appendix, Fig.
S5 B and C). We also found that human papillomavirus (HPV)
16 E7 inhibits neurite formation like 339LT. Expression of
hemagglutinin (HA)-tagged E7 significantly reduced T antigen
knockdown-induced neurite+ cells in MS-1 cells. Expression of
an Rb-binding mutant HA-E7.LYCYK, however, did not inhibit
neurite formation (SI Appendix, Fig. S5 D and E). Taken to-
gether, these results indicate that MCV LT expression, through
its Rb-binding domain, promotes Sox2 and Atoh1 expression
and suppresses the morphological conversion of MCC cells to
neurite+ cells.
Sox2 Directly Activates Atoh1 Expression and Is Essential for MCV+
MCC Cell Proliferation and the Inhibition of Neurite+ Cell Formation.




Fig. 5. The Rb-binding domain ofMCV LT regulates both activation of Sox2 and Atoh1 and inhibition of neurite+ cell formation. (A) Sox2 mRNA expression is induced by
truncated tumor-derived LT isolated 339 (339LT) in human keratinocytes, but not by the Rb binding mutant (339LT.LFCDK) or sT. Keratinocytes stably transduced with sT,
339LT, 339LT.LFCDK, and control (empty) lentiviruses were subjected to qRT-PCR analysis for Sox2 using 18S rRNA for normalization. The 2
−ΔΔCT method was used to
determine the relative mRNA abundance to shCtrl. Data are shown as average ± SD, *P < 0.05 (Student t test). (B) Wild-type shRNA-resistant 339LT rescues Sox2 and
Atoh1 expression under T antigen knockdown. MKL-2 cells stably transduced with codon-optimized 339LT, Rb-binding mutant 339LT.LFCDK, and control vector were
transduced with shCtrl-Neo or shpanT-Neo and selected with G418 for 6 d. After transduced cells were recovered in plain medium, cells were harvested for immunoblot to
examine Sox2 and Atoh1 protein expression. (C) 339LT inhibits T antigen knockdown-induced MKL-2 differentiation. Cells in B were cocultured with keratinocytes for 5 d
and photographed. (Magnification: 10×.) (D) MCC cell differentiation was evaluated according to the grading criteria in SI Appendix, Fig. S1F. Significance was determined
through the comparison between empty and 339LT (black bars) and between 339LT and 339LT.LFCDK (red bars). Data are shown as average ± SE, *P < 0.05 (Student t test).











Sox2 protein levels correlate with Atoh1 protein, but not with
KRT20 (SI Appendix, Fig. S6 A and B). This result suggests that,
as reported previously in normal Merkel cells (20), Sox2 may
directly regulate Atoh1 expression in MCV+ MCC cells. To ex-
amine this possibility, we knocked down endogenous Sox2 and
investigated its effect on Atoh1 expression. When MS-1, MKL-2,
and CVG-1 cells were transduced with 2 shRNAs, shSox2.1 and
shSox2.2, Sox2 mRNA expression was knocked down markedly
in MS-1 and MKL-2, and moderately in CVG-1 cells (Fig. 6 A,
Upper). In the same samples, we also observed a moderate but
concomitant decrease of Atoh1 mRNA expression, consistent
with the Sox2 regulation of Atoh1 mRNA expression (Fig. 6 A,
Lower). While Atoh1 mRNA reduction is moderate in MKL-2
and CVG-1 cells, the Atoh1 protein level was markedly de-
creased by 2 Sox2 shRNAs (Fig. 6B). To investigate the Sox2
regulation of the Atoh1 gene promoter, we then performed a
chromatin immunoprecipitation (ChIP) assay. The Atoh1 pro-
moter contains 2 Sox2 binding consensus motifs within 1,500 bp of
the proximal promoter to the TSS (Fig. 6C). The ChIP experiment






Fig. 6. Sox2 directly activates Atoh1 expression, promotes MCV+MCC cell proliferation, and inhibits neurite+ cell formation. (A) Knockdown of Sox2 reduces
Atoh1 mRNA expression. MS-1, MKL-2, and CVG-1 shCtrl-puro or 2 Sox2 shRNAs, shSox2.1-puro and shSox2.2-puro, were selected for 4 d and harvested at day
6 postinfection. Total RNAs were subjected to qRT-PCR analyses for Sox2 (Upper, black bars) and Atoh1 mRNA (Lower, gray bars) using 18S rRNA for normal-
ization. Data are shown as average ± SD, *P < 0.05 (Student t test). (B) shRNA knockdown of Sox2 reduces Atoh1 protein expression. Samples harvested in Awere
subjected to immunoblot analyses to examine Sox2 and Atoh1 protein expression. Hsc70 was used as an internal control. The LI-COR Odyssey system was used to
quantitate Sox2 (Upper, black bars) and Atoh1 (Lower, gray bars) protein expression with Hsc70 as a normalization control. (C) A schematic of the Atoh1 promoter
region shows 2 potential conserved Sox2 binding sites upstream of the TSS, and 4 sets of qPCR primers are designed as indicated. (D) qPCR analysis of Sox2 ChIP at
the promoter region of the Atoh1 gene shows the binding of Sox2 to sites C and D compared to negative control regions (NC: noncoding region and actin) in
MKL-2 cells. Data are shown as average ± SE, *P < 0.05 (1-way ANOVA). (E) Knockdown of Sox2 ablates MCV+ MCC cell proliferation. Three MCV+ MCC cell lines
with Sox2 knockdown in B were subjected toWST8 cell proliferation assays. (F) Like T antigen knockdown, Sox2 knockdown in CVG-1 and MS-1 increases neurite+
cells similar to T antigen knockdown. (Magnification: 10×.) (G) Neurite+ CVG-1 (F, Upper) or MS-1 (F, Lower) cells displaying grade 3 differentiation are significantly
induced by shSox2.1-puro (F, Center), similarly to T antigen knockdown (F, Right). Differentiation was graded according to the criteria in SI Appendix, Fig. S1E. Data are
shown as average ± SE, *P < 0.05 (Student t test).
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to the proximal Atoh1 promoter region (C and D) compared to
the distal promoter region (A and B) or negative control regions
(NC and actin) that do not contain predicted Sox2 binding sites
(Fig. 6D). This Sox2 binding site is distinct from the previously
defined mouse Atoh1 enhancer region that also contains
Sox2 binding motifs (20). Taken together, these results indicate
that Sox2 directly activates the transcription of the Atoh1.
Sox2 is an oncogene for cancers with stem cell properties, and
its activity is essential for cancer stem cell (CSC) self-renewal or
proliferation (41). We next examined if Sox2 functions as an
effector of viral T antigen and contributes to tumorigenesis.
Sox2 knockdown completely ablated the cell proliferation ac-
tivities of all 3 MCV+ cell lines (Fig. 6E). Since our results in-
dicate Sox2 is an upstream regulator of Atoh1(Fig. 6 B and D),
we knocked down Atoh1 alone to investigate the role of Atoh1 in
MCC cell proliferation. The knockdown of Atoh1 protein ex-
pression by shAtoh1 was nearly 90% in MKL-2, but was mod-
erate in MS-1 (50%) and CVG-1 (65%) cells (SI Appendix, Fig.
S6C). Under these conditions, modest growth inhibition was
observed in MS-1 and MKL-2, while no inhibition was seen in
CVG-1 cells (SI Appendix, Fig. S6D). These data suggest that in
MKL-2 and MS-1 cells, Atoh1 may also contribute to MCC cell
proliferation as a downstream effector of Sox2; this notion is
corroborated by our previous observation that increased Atoh1
expression correlates with aggressiveness of MCC (42).
Finally, we examined if the loss of Sox2 results in the forma-
tion of neurite+ cells. When CVG-1 and MS-1 cells were trans-
duced with shSox2.1 and cocultured with keratinocytes for 5 d,
neurite+ cells were significantly increased, as seen upon T anti-
gen knockdown (Fig. 6F). The grade 3 neurite+ cells were
markedly increased, while we did not observe a significant in-
crease for the grade 2 MCC differentiation (Fig. 6G). These data
indicate that Sox2 is the key transcription factor that maintains
the proliferative state of tumor cells and inhibits the morpho-
logical conversion to neurite+ cells.
Discussion
Cellular transformation or immortalization induced by SV40 T
antigen from a nonhuman primate polyomavirus is fully addicted
to its oncoprotein expression. Thus, the tumorigenicity is re-
versible by the inactivation of its T antigen expression. Pancreatic
β-cell tumors immortalized by SV40 LT can be reverted to
functional β-cells in transgenic mice (43). Rat heart smooth-
muscle cells, human hepatocytes, and human ensheathing glia
cells, which are conditionally immortalized by SV40 T antigen,
have also been shown to restore their cellular function with
growth arrest upon the inactivation of T antigen (44–46). In this
study, we examined whether human cancer, which was trans-
formed by the first oncogenic polyomavirus MCV, can also be
reverted to an untransformed state by the viral T antigen inhibition.
Our current data indicate that 1) the Sox2–Atoh1 pathway activated
by the Rb-binding domain of viral LT appears to be important for
both the manifestation of a Merkel cell phenotype and tumori-
genesis, and that 2) the in vitro inhibition of this pathway converts
MCC tumor cells to differentiated neuronal cells, but not Merkel
cells in the presence of cocultured keratinocytes (Fig. 7).
This study may also provide clues to a fundamental question:
Why does MCV induce cancers with a Merkel cell phenotype?
MCC is a neuroendocrine tumor, possessing gene-expression
signatures similar to mechanoreceptor Merkel cells. Atoh1 and
Sox2 are essential transcription factors that regulate Merkel cell
development in mice. Atoh1 is a proneural transcription factor
required for initial Merkel cell differentiation during Merkel cell
development. The conditional knockout of Atoh1 in Hoxb1+ skin
epithelial and dermal cells in embryos ablates Merkel cells in
mice (18). Sox2 also plays important roles in Merkel cell matu-
ration and maintenance during embryonic Merkel cell develop-
ment, and the conditional knockout of Sox2 in KRT14+
embryonic epidermal cells significantly reduces Merkel cell
numbers (19–21). Atoh1 and Sox2 are highly expressed in MCC
tumors (40, 42, 47), thereby likely contributing to the manifesta-
tion of a Merkel cell-like phenotype in MCC tumors. The genomic
amplification of MITF, a master regulator of melanocyte devel-
opment, is critical for melanomagenesis (48). Thus, as MITF ac-
tivation is linked to melanocyte lineage-specific transformation,
the viral activation of the Sox2-Atoh1 oncogenic pathway could
drive Merkel cell lineage-restricted carcinogenesis.
While the etiological role of MCV in MCC pathogenesis is
clear, cells of MCC origin infected by MCV and transformed by
MCV T antigen expression remain unknown. Initially, it was
assumed that MCC tumors arise from transformed mechanore-
ceptor Merkel cells because of the ultrastructural and gene-
expression similarities between normal Merkel cells and MCC
(49, 50). Recent studies have proposed that the cellular origin of
MCC may not be Merkel cells, and multiple cellular origins, such
as epidermal stem cells or pro/pre-B cells were suggested for
MCC (36, 51–53). Merkel cells are found at the basal layer of the
epidermis and make synaptic contacts with nerve endings to form
the Merkel cell–neurite complex for tactile sensing. In order to
transmit signals to afferent nerves, Merkel cells fire action po-
tentials by voltage-gated calcium channels (28) while voltage-
gated sodium channels drive the action potential firing in most
excitable cells. In our study, the T antigen knockdown not only
decreased Sox2 and Atoh1 expression, but also developed neu-
ronal but non-Merkel cell electrophysiological properties in
neurite+ cells, consistent with phenotypic conversion of MCC
into neuron-like cells. These data suggest a possibility that MCC
arises from precursor cells endowed with the potential to dif-
ferentiate into neuron-like, but not Merkel, cells (Fig. 7).
MCC typically localizes within the dermis layer, and less than
10% of MCC are associated with the epidermis as seen in the
rare cases of in situ MCC (54). This difference in tumor locali-
zation also infers that MCC may arise from different cells of
origin (52, 55). Verhaegen et al. (56) reported transgenic mice
that develop MCC-like tumors by expressing MCV sT and Atoh1
under the KRT5 promoter. Strikingly, the pathogenesis of MCC-
like tumors in this model was confined to the epidermal layers,
similar to in situ MCC or Merkel cell hyperplasia (57). These
data suggests a possibility that a rare epidermal MCC known as
in situ MCC may arise from Merkel cell precursors, whereas
most of MCV+ MCCs confined to the dermis may arise from
neuronal precursor cells (58). Thus, it can be hypothesized that the
dermis serves as the “stem cell niche” for the MCV-transformed
neuronal precursor cells by preventing spontaneous differenti-
ation stimulated by physical contact with the keratinocytes in
the epidermis.
Initially, it was demonstrated that the knockdown of viral T an-
tigen induces partial nonapoptotic cell death in MCV+ cells (10).
On the other hand, in the presence of keratinocytes, T antigen
Fig. 7. A model of MCV+ MCC genesis. Sox2, which is activated by MCV LT
through the LXCXE Rb-binding domain induces Atoh1 and maintains tu-
morigenic state of MCC cells, inhibiting the phenotypic conversion of MCC
cells to differentiated neuron-like cells. MCV may transform yet-to-be-
defined neuronal precursor cells into Merkel cell-like cancer cells.











knockdown promoted a phenotypic conversion of MCC cells to
neuron-like cells, instead of inducing cell death. Since our results
indicate that neurite outgrowth requires the presence of keratino-
cytes, cellular signaling from keratinocytes may support cell survival
and the differentiation of T antigen knockdown cells into neuron-
like cells. Further studies are needed to identify the keratinocyte-
mediated cell signaling that promotes the neuron-like differentia-
tion of MCC cells.
Our finding is consistent with recent results showing that the
Rb tumor suppressor inhibits the expression of Sox2 and Oct4
and restricts cellular reprogramming as well as tumorigenesis
(59). Rb has also been shown to be a repressor of cellular
reprogramming and the development of CSCs (60). Tumor
viruses have been suspected to target stem cells for trans-
formation (61–63), and the Rb protein is commonly inhibited by
tumor viruses (64). High-risk HPVs have been proposed to infect
stem cells (65, 66). A recent study showed that HPV16 prefer-
entially transforms basal keratinocytes with stem cell properties
(67) and that the HPV E7 oncoprotein, which inhibits Rb simi-
larly to MCV LT, activates pluripotency genes, including Oct4,
Sox2, and Nanog (68). Thus, the targeting of cellular repro-
gramming factors, such as Sox2 and Oct4, may be a common
mechanism for stem cell transformation by tumor viruses.
Sox2 can act as an oncogenic reprogramming factor and is
expressed predominantly in cancer-initiating cells or CSCs (41).
For many CSC-associated tumors, Sox2 is an essential oncogene
and drives the self-renewal of transformed stem cells (41). If
MCV+MCCs have properties similar to CSC-associated cancers,
a specific therapy targeting the self-renewal of stem cells (e.g.,
therapies targeting Notch, WNT, and so forth) may be a fruitful
direction of investigation.
Experimental Procedures
Coculture Experiments and Grading of Neurite Formation. Keratinocytes were
seeded at 20%density in 6-well plates a day before the coculture experiment.
Approximately 105 of MCV+ MCC cells were washed with PBS once, sus-
pended in keratinocyte medium, and transferred to the keratinocytes in a 6-
well plate for coculture. At days 5 to 8 of coculture, the neurite outgrowth
was graded from 0 to 3 according to its polarization and the relative neurite
length to the cell body. Grade 0 represents no process, grade 1 cellular
process-positive, grade 2 polarized projections, and grade 3 with projection
longer than 2-cell body size. The neurite formation assays shown in Figs. 1C,
5D, and 6G and SI Appendix, Fig. S4 were evaluated by 4 different individ-
uals. More than 250 cells were examined on the printed photographs in
order to grade the neurite formation in a blinded and randomized fashion.
Neurite+ CVG-1 cells representing each grade (SI Appendix, Fig. S1E) were
used as a reference when evaluated.
Statistics. Student’s t test was used for qRT-PCR and neurite formation assays
to determine statistically significant differences, and 1-way ANOVA was
used for Sox2 ChIP experiments. Detailed materials and methods used for
cell lines, plasmids, lentivirus production and infection, qRT-PCR, immunoblots,
immunofluorescence, electron microscopy imaging, proliferation assays,
whole cell patch clamp recording, single cell RNA sequencing and data
analysis, DNA methylation analysis, and ChIP assay are provided in SI
Appendix, SI Experimental Procedures.
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